Pharmaceutical cognitive enhancement: Interrogating the ethics, addressing the issues

Augmenting Cognition

Volumn , Issue , 2011, Pages 179-192

  Martin, Paul A ^a   Pickersgill, Martyn ^b   Coveney, Catherine ^c   Williams, Simon ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863420344     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (31)

1. Farah MJ. "Emerging ethical issues in neuroscience", Nature Neuroscience, 2002;5(11):1123-1129.
2. Farah MJ, Iles J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR. "Neurocognitive enhancement: what can we do and what should we do?", Nature Reviews Neuroscience, 2004;5(5):421-425.
3. Farah MJ. "Neuroethics: the practical and the philosophical", Trends in Cognitive Sciences, 2005;9(1):34-40.
4. Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ. "Towards responsible use of cognitive-enhancing drugs by the healthy", Nature, 2008;456:702-705.
5. Harris J. (2007) Enhancing Evolution, Princeton and Woodstock, Princeton University Press.
6. Sahakian B, Morein-Zamir S. "Professor's little helper", Nature, 2007;450:1157-1159.
7. Foresight Mental Capital and Wellbeing Project (2008) Final Project Report - Executive Summary, London: The Government Office for Science.
8. Shorter Oxford English Dictionary (2007). Oxford: OUP.
9. Glannon W. Neuroethics, Bioethics, 2006;20(1):37-52.
10. Butcher J. "Cognitive enhancement raises ethical concerns" The Lancet, 2003;362:132-133.
11. Hyman SE. "Improving our brains?" BioSocieties, 2006;1:103-111.
12. Williams SJ, Katz S, Martin P. (2011 - forthcoming) "Neuroscience and Medicalisation: Sociological Reflections on Memory, Medicine and the Brain." In van Keulen, I. and Pickersgill, M. (eds.) Sociology Reflections on the Neurosciences. Emerald Insight.
13. Babcock Q, Byrne T. "Student perceptions of methylphenidate abuse at a public liberal arts college" Journal of American College Health, 2000;49(3):143-145.
14. DeSantis AD, Webb EM, Noar SM. "Illicit use of prescription ADHD medications on a college campus: a multimethodological approach", Journal of American College Health, 2008;57(3):315-324.
15. DuPont RL, Coleman JJ, Bucher RH, Wilford BB. "Characteristics and motives of college students who engage in nonmedical use of methylphenidate", American Journal on Addictions, 2008;17(3):167-171.
16. Esteban McCabe S, Knight JR, Teter CJ, Wechsler H. "Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey", Addiction, 2005;100(1):96-106.
17. Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. "Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample", Journal of American College Health, 2005;53(6):253-262.
18. Coveney C.M. (2010) Awakening Expectations: exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK. PhD thesis, University of Nottingham.
19. Conrad P, Potter D. "Human growth hormone and the temptations of biomedical enhancement", Sociology of Health and Illness, 2004;26(2):184-215.
20. Turner DC, Sahakian BJ. "Neuroethics of cognitive enhancement", BioSocieties, 2006;1(1):113-123.
21. Lynch G, Gall CM. "Ampakines and the threefold path to cognitive enhancement", Trends in Neurosciences, 2006;29(10):554-562.
22. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian B. "Cognitive enhancing effects of Modafinil in healthy volunteers", Psychopharmacology, 2003;165:260-269.
23. Repantisa D, Schlattmann P, Laisneya O, Heuser I. "Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review" Pharmacological Research, 2010;62:187-206
24. Harris J. "Is it acceptable for people to take methylphenidate to enhance performance? Yes", BMJ, 2009;338: b1955.
25. Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, PotoskyAL, Sanders-Bush E, Silberberg D, Trevisan M. "National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer's Disease and Cognitive Decline" NIH Consens State Sci Statements. 2010;27(4):1-30.
26. Mehlman M J. "Cognition-enhancing drugs", The Millbank Quarterly, 2004;82(3):483-506.
27. Roth T, Schwartz JRL, Hirschkowitz M, Erman MK, Dayno JM, Arora S. "Evaluation of the safety of Modafinil for treatment of excessive sleepiness", Journal of Clinical Sleep Medicine, 2007;3(6):595-602.
28. European Medicine Agency (2010) EMA Restricts Use of Modafinil. Press Release. London: EMA.
29. Elliott C. (2003) Better Than Well: American Medicine Meets the American Dream, New York and London: W. W. Norton and Company.
30. Williams SJ, Seale C, Boden S, Lowe P, Steinberg DL. "Waking up to sleepiness: Modafinil, the media, and the pharmaceuticalisation of everyday/night life", Sociology of Health and Illness, 2008;30(6):839-855.
31. Maasen S, Sutter B. (2007) On Willing Selves: Neoliberal Politics and the Challenge of Neuroscience. Basingstoke: Macmillan.